Day: July 20, 2022

Projected Patient Shares Projected Patient Shares taken from Nephrology SurveyRenazorb product profile rated as best-in-class phosphate binder Nephrologists report high prescribing intent for Renazorb pending FDA approval LOS ALTOS, Calif., July 20, 2022 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced the results from a primary market research study conducted on behalf of the company by Reason Research, LLC. The study was a discrete-choice model (“conjoint”) analysis in which 100 US-based nephrologists were presented with various phosphate binder attributes, including efficacy, safety/tolerability, pill burden, composition (calcium or non-calcium based), and dose form (chewable or swallowed), in a trade-off...

Figure 1 – Solaris Warintza Central Drilling Zoom In Figure 1 – Solaris Warintza Central Drilling Zoom InVANCOUVER, British Columbia, July 20, 2022 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or “the Company”) is pleased to report assay results from a series of holes aimed at growing the Northeast Extension of the ‘Indicative Starter Pit’ at its Warintza Project (“Warintza” or “the Project”) in southeastern Ecuador. Highlights are listed below, with a corresponding image in Figure 1 and detailed results in Tables 1-2. Highlights Additional drilling has expanded the Northeast Extension of the ‘Indicative Starter Pit’ recently estimated at 180 Mt at 0.82% CuEq1 (Indicated) and 107 Mt at 0.73% CuEq1 (Inferred) within the Warintza Mineral Resource Estimate² (“MRE”). This zone is characterized...

SHENZHEN, China, July 20, 2022 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that the Company, founders and senior executives of the Company and investors entered into a share purchase agreement, a subscription agreement, a shareholders’ agreement and a cooperation agreement. THE SHARE PURCHASE AGREEMENT On July 20, 2022, the Company, Dr. Pengwu Zhou and Ms. Wenting Ding (the “Founders”), certain existing shareholders of the Company controlled by the Founders and Australia Wanda International Company Limited (“Wanda”) entered into a Share Purchase Agreement. Pursuant to the Share Purchase Agreement, Seefar Global Holdings Limited (“Seefar”), Jubilee Set Investments Limited (“Jubilee”),...

ANN ARBOR, Mich., July 20, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces the release of a behind the scenes look into its silkworm breeding facility in Vietnam. This video is the first in a series designed to bring the viewer inside the Company’s recombinant spider silk production operations. This video tour edition highlights the breeding and egg production center that the Company established in Vietnam, to support in-house and third-party contract manufacturing of its eco-responsible and cost-effective spider silk. Operated by its wholly owned Vietnamese subsidiary, the Company believes that this facility is now equipped to meet the production...

MALVERN, Pa., July 20, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that it has been awarded a group purchasing agreement for Synthetic Bioabsorbable Mesh Products with Premier, Inc. Effective October 1st, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OviTex® and OviTex PRS Reinforced Tissue Matrix. Premier (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 225,000 other providers and organizations to transform healthcare....

Figure 1 Geology map, Nuevo TintilloFigure 2 AS350B Turbine helicopterTable 1 Equipment and data sampling specificationsFigure 3 HTDEM Survey on the Nuevo Tintillo property, 100-spacing lines. Digital TerraneChart 1 Magnetic data processing flow diagramChart 2 Time Domain electromagnetic data processing flow diagramFigure 4 3D Voxet interpretation. On the east side, the extensive, strong conductors occur in the area of the small, past producing Santa Flora and Nazaret mines. These mines date to the early part of the last century before any modern exploration technology existed, yet this underexplored area is within sight of the giant Rio Tinto deposit further west.Figure 5 Two geophysical profiles, showing EM Conductors in the Nazaret historical mine area.TORONTO, July 20, 2022 (GLOBE NEWSWIRE) — Emerita...

GREENSBORO, N.C., July 20, 2022 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2023 first quarter financial results on Wednesday, August 3, 2022, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s website at the following URL: http://www.qorvo.com (under “Investors”). A telephone playback of the conference call will be available approximately two hours after the call’s completion and can be accessed by dialing 719-457-0820 and using the passcode 2097988. The playback will be available through the close of business August 10, 2022. Qorvo will distribute fiscal 2023 first quarter financial results at approximately 4:00 p.m. (ET) on Wednesday, August 3, 2022. About QorvoQorvo (Nasdaq: QRVO)...